Navigation Links
Hepatitis B Relapse In Cancer Chemotherapy Can Be Avoided By Antiviral Drug

A team of researchers led by Jeong Won Jang of the Department of Internal Medicine at the Catholic University of Korea in Seoul, has found // that administering an antiviral drug would help prevent hepatitis B relapse in patients who are undergoing chemotherapy for the treatment of cancer.

In hepatocellular carcinoma (HCC), patients have a 55 percent chance of developing hepatitis B as a result of chemotherapy. Hepatocellular carcinoma or liver cancer is caused by hepatitis B virus. Now researchers say that giving antiviral drug lamivudine in order to prevent hepatitis B returning during chemotherapy will benefit patients in the long run. In the current study 36 patients with HCC were pretreated with lamivudine between January 2004 and February 2005.All these patients were on transarterial chemo-lipiodolization (TACL) chemotherapy. Another group of 37 patients who were undergoing chemotherapy were used as a control. The number of chemotherapy cycles was unlimited and went on till the tumors disappeared while lamivudine was continued for a year after the chemotherapy was stopped. It was found that 43 percent of the patients in the control group developed hepatitis B, while only 17 percent of the lamivudine group developed it. "Given that preemptive antiviral therapy ameliorates the hepatic morbidity seen during transarterial chemotherapy and facilitates further chemotherapy without disruptions in the treatment schedules, the expectation would be for an increased chance of survival with this approach," the authors conclude.

The study is published in the February 2006 issue of Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD). Published by John Wiley & Sons, Inc., Hepatology is available online via Wiley InterScience at http://www.interscience.wiley.com/journal/hepatology. Original Article: "A Randomized Controlled Study of Preemptive Lamivudine in Patients Receiving Transarterial Chemo-Lipiod olization," Jeong Won Jang, Jong Young Choi, Si Hyun Bae, Seung Kew Yoon, U Im Chang, Chang Wook Kim, Se Hyun Cho, Jun Yeol Han, Young Sok Lee, Hepatology; February 2006 (DOI: 10.1002.hep.21024). Contact: David Greenberg dgreenbe@wiley.com John Wiley & Sons, Inc.
'"/>




Related medicine news :

1. Vitamin B for Hepatitis
2. Hepatitis G May Boost HIV Survival
3. Cure for Hepatitis B
4. Hepatitis E virus made impotent
5. Sharing injection equipment spreads Hepatitis C
6. Lymphomas Link to Hepatitis C
7. Hepatitis shots is promising
8. Need for Hepatitis Booster Questioned
9. Good News for HIV Patients Also Suffering From Hepatitis C Virus
10. The Link Between Hepatitis B Vaccine And Multiple Sclerosis Questioned
11. The Effectiveness Of Hepatitis B Vaccine Questioned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... Braunfels, TX (PRWEB) , ... March 23, 2017 , ... ... new clinic, located at 960 Gruene Road in Building 2. The clinic is the ... Dr. Andrew Bennett, PT, says opening the company’s second New Braunfels location brings things ...
(Date:3/23/2017)... ... ... The IoT (Internet of Things) is revolutionizing the way the world operates. ... and individual consumers alike. Laboratories can maximize their profit margin by increasing throughput. ... trillion to $11 trillion dollars by the year 2025. McKinsey expects the IoT to ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... 82% of adults are unaware of the ... do not brush their teeth the minimum two times a day that dentists recommend. The ... missing 51 million hours of school and adults missing 164 million hours of work each ...
(Date:3/23/2017)... ... ... March is National Kidney Month – the perfect time to pause and ... health. Every day, two kidneys filter about 120 to 150 quarts of blood. Put ... waste, regulating fluid levels and blood pressure, supporting bone health and promoting red blood ...
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company announced today ... accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary ... have excellent programs for the delivery and improvement of disease management and that ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... DUBLIN , Mar 23, 2017 Research ... Electrophoresis Market 2017-2021" report to their offering. ... The global capillary electrophoresis market ... The report, Global Capillary Electrophoresis Market 2017-2021, has ... industry experts. The report covers the market landscape and its growth ...
(Date:3/23/2017)... -- CENTRO DE IMAGEM DIAGNOSTICOS S.A. (" Company "), ... 6,404/76 and Instruction 358/02 of the Brazilian Securities and ... market in general that it entered yesterday, as a ... Imagem Ltda. (" CDI "), into an agreement for ... (" Partnership " and " Acquisition "). ...
(Date:3/23/2017)... -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company ... unmet medical needs in rare diseases, today announced that ... on Monday, April 3 during ENDO 2017, the annual ... Florida , to discuss new data regarding its ... PTH and TransCon CNP). Ascendis is presenting ...
Breaking Medicine Technology: